Department of Health appoints new comms director
October 6, 2011Medical Communications appointment, medical communications
The Department of Health has appointed Sam Lister, currently health editor at The Times, as its new director of communications. …
Actavis plans ‘major’ sales expansion in Latin America
October 6, 2011Sales and Marketing Actavis, emerging markets, generics
Swiss company Actavis has launched a new business unit to target the fast-growing Latin American generics market. Mirroring the branded …
EMA tightens conflict of interest rules
October 6, 2011Research and Development, Sales and Marketing EMA
The European Medicines Agency is tightening up its conflict of interest rules with a new ‘experts database’. This will allow …
Merck appoints new chief strategy officer
October 6, 2011Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, research and development, sales and marketing
Cuong Viet Do has joined Merck & Co as chief strategy officer, replacing Mervyn Turner who retired from the US …
Call for open access to all clinical trial data
October 6, 2011Research and Development Cochrane, clinical trials, clinical trials analysis
There should be free access to all clinical trials in order to end selective reporting, according to a leading not-for-profit …
Merck KGaA signs MS and cancer research deal
October 5, 2011Research and Development Merck KGaA
Merck KGaA has signed development deals with Japanese firm Ono Pharmaceutical Co around two investigational treatments, one for multiple sclerosis …
NICE to review wider use of off-label prescribing
October 5, 2011Sales and Marketing off label, off label prescribing
The government has asked NICE to review its plans to give doctors greater freedom for ‘off-label’ prescribing. It wants NICE, …
Blocking pain – a long-term mission for pharma research
October 5, 2011Research and Development chronic pain, neuropathic pain, pain therapeutics
Pain is a common, yet complex, clinical problem and one which remains an area of unmet need. There are however, …
Steve Mott joins DrugLogic
October 5, 2011Research and Development appointment, outcomes research, personalised medicine, pharmacovigilance, research and development
Former Datapharm Communications chief executive Steve Mott has been apppointed UK managing director by DrugLogic.The US firm develops analytical tools …
Contract research news in brief
October 5, 2011Research and Development research and development news
Clinipace raises $15m, PPD appoints a new chief executive and there are updates from Quintiles, PharmaNet and DaVita Clinical Research. …
Health reforms will do ‘irreparable’ damage to public health
October 4, 2011NHS reforms
Doctors have urged the House of Lords to reject the Health and Social Care Bill, saying the proposed legislation will …
Adaptimmune makes board appointments
October 4, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
UK and US-based cell therapy company Adaptimmune has made two new appointments to its board. Dr Jonathan Knowles joins as …
Manufacturing makes a comeback at Roche’s Nutley site
October 4, 2011Manufacturing and Production Roche, pharma manufacturing news
Roche has opened a new manufacturing facility at its campus in Nutley, New Jersey, that will supply dosage forms for …
Merck pays $1.5m penalty for US pollution
October 4, 2011Manufacturing and Production Merck & Co, pharma manufacturing news
Merck & Co has fallen foul of US regulations on environmental controls at two manufacturing plants and agreed to pay …
Digital Pharma: NHS-backed health social network launches
October 3, 2011Medical Communications Digital Pharma blog, NHS, social media
A new NHS-backed social network has launched to provide support to patients with long-term conditions through ‘personal health planning’. How …
Pharma manufacturing news in brief
October 3, 2011Manufacturing and Production pharma manufacturing news
Our round-up of pharma manufacturing news sees a green energy drive from GSK, facility updates from Stirling Pharma, Reckitt Benckiser …
Takeda completes Nycomed acquisition, installs new chief executive
October 3, 2011Sales and Marketing Nycomed, Takeda
Takeda Pharmaceutical Company has completed its acquisition of Nycomed and named Frank Morich as chief executive of the Zurich-based firm. …
Trial disappointment for AZ lung cancer drug
October 3, 2011Research and Development, Sales and Marketing AstraZeneca, selumetinib
AstraZeneca’s lung cancer drug selumetinib has failed to hit its primary endpoint in a Phase II trial. The trial compared …
SHL receives Good Design Award for Molly Auto Injector
October 3, 2011Manufacturing and Production auto injector, autoinjector, good design award, molly
SHL Group is honored to have recently received certification for the Good Design Award for its revolutionary auto injector, Molly. …
Jean-Pierre Garnier elected chairman of Actelion
October 3, 2011Sales and Marketing appointment, sales and marketing
Jean-Pierre Garnier has been elected chairman of Swiss biopharmaceutical company Actelion. He has sat on the company’s board since May …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
